Patients squeezed in fight over who gets to bill for pricey infusion drugs

FHS
July 5, 2023
10:36 am

Health insurers and medical providers are battling over who should supply high-cost infusion drugs for patients, with the tussle over profits now spilling into statehouses across the country.

Exclusive: A small San Diego biotech wants to change how Parkinson’s disease is diagnosed

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 9, 2024

Theramex gains European rights to Duphaston and Femoston from Viatris – Pharmaceutical Technology

Dydrogesterone and estradiol + dydrogesteroneare are widely used for the treatment of women’s health. Image credit: Shutterstock/Ground Picture. Theramex has entered into an agreement with

October 10, 2023

Deep-learning technology could help scientists to develop personalized immunotherapies and vaccines

Deep-learning technology developed by a team of Johns Hopkins engineers and cancer researchers can accurately predict cancer-related protein fragments that may trigger an immune system

August 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.